monoclonal antibodies

Angie Szumlinski
|
August 18, 2021
NIH Statement on Casirivimab Plus Imdevimab as PEP

Angie Szumlinski
|
July 7, 2021
Monoclonal Antibody Therapy Paused

Angie Szumlinski
|
June 24, 2021
Research and More Research

Angie Szumlinski
|
April 9, 2021
FDA Monoclonal Antibody Therapy Update
Stay informed with Angie’s expert perspective on current clinical challenges, industry trends, and real-world risk insights.
